Bioreducible polycations as shuttles for therapeutic nucleic acid and protein transfection

Antioxidants and Redox Signaling

Volumn 21, Issue 5, 2014, Pages 804-817

  Klein, Philipp M ^a   Wagner, Ernst ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIDE; NANOCARRIER; NUCLEIC ACID; OLIGOMER; PEPTIDE; POLYCATION; POLYMER; PROTEIN; SMALL INTERFERING RNA; TOXIN; POLYAMINE; POLYCATIONS;

AMINO ACID SEQUENCE; BIOCOMPATIBILITY; CELL COMPARTMENTALIZATION; CELL SURFACE; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; COMPLEX FORMATION; COVALENT BOND; CYTOSOL; DISULFIDE BOND; DNA TRANSFECTION; ENDOSOME; EXTRACELLULAR MATRIX; IN VITRO STUDY; MACROMOLECULE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; REVIEW; SHEAR STRESS; SIGNAL TRANSDUCTION; VIRUS; CHEMISTRY; GENETIC TRANSFECTION; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION; PROCEDURES;

HUMANS; NUCLEIC ACIDS; OXIDATION-REDUCTION; POLYAMINES; PROTEINS; TRANSFECTION;

EID: 84904443084     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5714     Document Type: Review

References (131)

1. Behr JP. The proton sponge: a trick to enter cells the viruses did not exploit. Chimia 51: 34-36, 1997.
2. Benjaminsen RV, Mattebjerg MA, Henriksen JR, Moghimi SM, and Andresen TL. The possible "proton sponge" effect of polyethylenimine (PEI) does not include change in lysosomal pH. Mol Ther 21: 149-157, 2013.
3. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, and Behr JP. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 92: 7297-7301, 1995.
4. Breunig M, Lungwitz U, Liebl R, and Goepferich A. Breaking up the correlation between efficacy and toxicity for nonviral gene delivery. Proc Natl Acad Sci USA 104: 14454-14459, 2007.
5. Brulisauer L, Kathriner N, Prenrecaj M, Gauthier MA, and Leroux JC. Tracking the bioreduction of disulfide-containing cationic dendrimers. Angew Chem Int Ed Engl 51: 12454-12458, 2012.
6. Bumcrot D, Manoharan M, Koteliansky V, and Sah DW. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2: 711-719, 2006.
7. Burke RS and Pun SH. Extracellular barriers to in vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver. Bioconjug Chem 19: 693-704, 2008.
8. Cerritelli S, Velluto D, and Hubbell JA. PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery. Biomacromolecules 8: 1966-1972, 2007.
9. Chen X, Bai Y, Zaro JL, and Shen WC. Design of an in vivo cleavable disulfide linker in recombinant fusion proteins. Biotechniques 49: 513-518, 2010.
10. Chen X, Dudgeon N, Shen L, and Wang JH. Chemical modification of gene silencing oligonucleotides for drug discovery and development. Drug Discov Today 10: 587-593, 2005.
11. Choi S and Lee KD. Enhanced gene delivery using disulfide-crosslinked low molecular weight polyethylenimine with listeriolysin o-polyethylenimine disulfide conjugate. J Control Release 131: 70-76, 2008.
12. Christensen LV, Chang CW, Kim WJ, Kim SW, Zhong Z, Lin C, Engbersen JF, and Feijen J. Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. Bioconjug Chem 17: 1233-1240, 2006.
13. Dalkara D, Chandrashekhar C, and Zuber G. Intracellular protein delivery with a dimerizable amphiphile for improved complex stability and prolonged protein release in the cytoplasm of adherent cell lines. J Control Release 116: 353-359, 2006.
14. Debs RJ, Freedman LP, Edmunds S, Gaensler KL, Duzgunes N, and Yamamoto KR. Regulation of gene-expression invivo by liposome-mediated delivery of a purified transcription factor. J Biol Chem 265: 10189-10192, 1990.
15. DeLeve LD and Kaplowitz N. Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther 52: 287-305, 1991.
16. DeRouchey J, Schmidt C, Walker GF, Koch C, Plank C, Wagner E, and Rädler JO. Monomolecular assembly of siRNA and Poly(ethylene glycol)-peptide copolymers. Biomacromolecules 9: 724-732, 2008.
17. Didenko VV, Ngo H, and Baskin DS. Polyethyleneimine as a transmembrane carrier of fluorescently labeled proteins and antibodies. Anal Biochem 344: 168-173, 2005.
18. Dohmen C, Edinger D, Frohlich T, Schreiner L, Lachelt U, Troiber C, Radler J, Hadwiger P, Vornlocher HP, and Wagner E. Nanosized multifunctional polyplexes for receptor-mediated SiRNA delivery. ACS Nano 6: 5198-5208, 2012.
19. Dohmen C, Frohlich T, Lachelt U, Rohl I, Vornlocher H-P, Hadwiger P, and Wagner E. Defined Folate-PEGsiRNA conjugates for receptor-specific gene silencing. Mol Ther Nucleic Acids 1: e7, 2012.
20. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498, 2001.
21. Fass D. Disulfide bonding in protein biophysics. Annu Rev Biophys 41: 63-79, 2012.
22. Feener EP, Shen WC, and Ryser HJ. Cleavage of disulfide bonds in endocytosed macromolecules. A processing not associated with lysosomes or endosomes. J Biol Chem 265: 18780-18785, 1990.
23. Felgner PL, Barenholz Y, Behr JP, Cheng SH, Cullis P, Huang L, Jessee JA, Seymour L, Szoka F, Thierry AR, Wagner E, and Wu G. Nomenclature for synthetic gene delivery systems. Hum Gene Ther 8: 511-512, 1997.
24. Fidias P, Grossbard M, and Lynch TJ, Jr. A phase II study of the immunotoxin N901-blocked ricin in small-cell lung cancer. Clin Lung Cancer 3: 219-222, 2002.
25. Filpula D, Yang K, Basu A, Hassan R, Xiang L, Zhang Z, Wang M, Wang QC, Ho M, Beers R, Zhao H, Peng P, Zhou J, Li X, Petti G, Janjua A, Liu J, Wu D, Yu D, Longley C, FitzGerald D, Kreitman RJ, and Pastan I. Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in mice. Bioconjug Chem 18: 773-784, 2007.
26. Forrest ML, Koerber JT, and Pack DW. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjug Chem 14: 934-940, 2003.
27. Frankel AD and Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55: 1189-1193, 1988.
28. Fröhlich T, Edinger D, Kläger R, Troiber C, Salcher E, Badgujar N, Martin I, Schaffert D, Cengizeroglu A, Hadwiger P, Vornlocher H-P, and Wagner E. Structure-activity relationships of siRNA carriers based on sequencedefined oligo (ethane amino) amides. J Control Release 160: 532-541, 2012.
29. Frohlich T, Edinger D, Russ V, and Wagner E. Stabilization of polyplexes via polymer crosslinking for efficient siRNA delivery. Eur J Pharm Sci 47: 914-920, 2012.
30. Futami J, Kitazoe M, Maeda T, Nukui E, Sakaguchi M, Kosaka J, Miyazaki M, Kosaka M, Tada H, Seno M, Sasaki J, Huh NH, Namba M, and Yamada H. Intracellular delivery of proteins into mammalian living cells by polyethylenimine-cationization. J Biosci Bioeng 99: 95-103, 2005.
31. Gosselin MA, Guo W, and Lee RJ. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug Chem 12: 989-994, 2001.
32. Grandinetti G, Ingle NP, and Reineke TM. Interaction of poly(ethylenimine)-DNA polyplexes with mitochondria: implications for a mechanism of cytotoxicity. Mol Pharm 8: 1709-1719, 2011.
33. Green M and Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55: 1179-1188, 1988.
34. Han S, Mahato RI, Sung YK, and Kim SW. Development of biomaterials for gene therapy. Mol Ther 2: 302-317, 2000.
35. Hartmann L. Polymers for Control Freaks: Sequence-Defined Poly(amidoamine)s and Their Biomedical Applications. Macromol Chem Phys 212: 8-13, 2011.
36. Hartmann L, Hafele S, Peschka-Suss R, Antonietti M, and Borner HG. Tailor-made Poly(amidoamine)s for controlled complexation and condensation of DNA. Chemistry 14: 2025-2033, 2008.
37. Hartmann L, Häfele S, Peschka-Süss R, Antonietti M, and Börner HG. Sequence positioning of disulfide linkages to program the degradation of monodisperse Poly(amidoamines). Macromolecules 40: 7771-7776, 2007.
38. Hartmann L, Krause E, Antonietti M, and Borner HG. Solid-phase supported polymer synthesis of sequencedefined, multifunctional poly(amidoamines). Biomacromolecules 7: 1239-1244, 2006.
39. Holmgren A and Bjornstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol 252: 199-208, 1995.
40. Ibrahim AF, Weirauch U, Thomas M, Grunweller A, Hartmann RK, and Aigner A. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 71: 5214-5224, 2011.
41. Itaka K, Harada A, Yamasaki Y, Nakamura K, Kawaguchi H, and Kataoka K. In situ single cell observation by fluorescence resonance energy transfer reveals fast intracytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine. J Gene Med 6: 76-84, 2004.
42. Joliot A, Pernelle C, Deagostini-Bazin H, and Prochiantz A. Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci USA 88: 1864-1868, 1991.
43. Jones DP, Carlson JL, Samiec PS, Sternberg P, Jr., Mody VC, Jr., Reed RL, and Brown LA. Glutathione measurement in human plasma. Evaluation of sample collection, storage and derivatization conditions for analysis of dansyl derivatives by HPLC. Clin Chim Acta 275: 175-184, 1998.
44. Joshua-Tor L. siRNAs at RISC. Structure 12: 1120-1122, 2004.
45. June RK, Gogoi K, Eguchi A, Cui XS, and Dowdy SF. Synthesis of a pH-sensitive nitrilotriacetic linker to peptide transduction domains to enable intracellular delivery of histidine imidazole ring-containing macromolecules. J Am Chem Soc 132: 10680-10682, 2010.
46. Kale AA and Torchilin VP. "Smart" drug carriers: PEGylated TATp-modified pH-sensitive liposomes. J Liposome Res 17: 197-203, 2007.
47. Kellogg BA, Garrett L, Kovtun Y, Lai KC, Leece B, Miller M, Payne G, Steeves R, Whiteman KR, Widdison W, Xie H, Singh R, Chari RV, Lambert JM, and Lutz RJ. Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage. Bioconjug Chem 22: 717-727, 2011.
48. Kim TI and Kim SW. Bioreducible polymers for gene delivery. Reactive Funct Polym 71: 344-349, 2011.
49. Kloeckner J, Bruzzano S, Ogris M, and Wagner E. Gene carriers based on hexanediol diacrylate linked oligoethylenimine: effect of chemical structure of polymer on biological properties. Bioconjug Chem 17: 1339-1345, 2006.
50. Knorr V, Allmendinger L, Walker GF, Paintner FF, and Wagner E. An acetal-based PEGylation reagent for pHsensitive shielding of DNA polyplexes. Bioconjug Chem 18: 1218-1225, 2007.
51. Knorr V, Ogris M, and Wagner E. An acid sensitive ketalbased polyethylene glycol-oligoethylenimine copolymer mediates improved transfection efficiency at reduced toxicity. Pharm Res 25: 2937-2945, 2008.
52. Koo H, Jin GW, Kang H, Lee Y, Nam K, Zhe Bai C, and Park JS. Biodegradable branched poly(ethylenimine sulfide) for gene delivery. Biomaterials 31: 988-997, 2010.
53. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, and Mendell JT. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137: 1005-1017, 2009.
54. Kuai R, Yuan W, Qin Y, Chen H, Tang J, Yuan M, Zhang Z, and He Q. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes. Mol Pharm 7: 1816-1826, 2010.
55. Kukowska-Latallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, and Baker JR, Jr. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci USA 93: 4897-4902, 1996.
56. Kursa M, Walker GF, Roessler V, Ogris M, Roedl W, Kircheis R, and Wagner E. Novel shielded transferrinpolyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjug Chem 14: 222-231, 2003.
57. Kwok A and Hart SL. Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA delivery. Nanomedicine 7: 210-219, 2011.
58. Lee SY, Huh MS, Lee S, Lee SJ, Chung H, Park JH, Oh YK, Choi K, Kim K, and Kwon IC. Stability and cellular uptake of polymerized siRNA (poly-siRNA)/polyethylenimine (PEI) complexes for efficient gene silencing. J Control Release 141: 339-346, 2010.
59. Lee Y, Ishii T, Kim HJ, Nishiyama N, Hayakawa Y, Itaka K, and Kataoka K. Efficient delivery of bioactive antibodies into the cytoplasm of living cells by chargeconversional polyion complex micelles. Angew Chem Int Ed Engl 49: 2552-2555, 2010.
60. Letvin NL, Goldmacher VS, Ritz J, Yetz JM, Schlossman SF, and Lambert JM. In vivo administration of lymphocytespecific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates. J Clin Invest 77: 977-984, 1986.
61. Lew D, Parker SE, Latimer T, Abai AM, Kuwahara-Rundell A, Doh SG, Yang Z-Y, Laface D, Gromkowski SH, Nabel GJ, Manthorpe M, and Norman J. Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice. Hum Gene Ther 6: 553-564, 1995.
62. Liguori L, Marques B, Villegas-Mendez A, Rothe R, and Lenormand JL. Liposomes-mediated delivery of proapoptotic therapeutic membrane proteins. J Control Release 126: 217-227, 2008.
63. Lin C, Blaauboer C-J, Timoneda MM, Lok MC, van Steenbergen M, Hennink WE, Zhong Z, Feijen J, and Engbersen JFJ. Bioreducible poly(amido amine)s with oligoamine side chains: synthesis, characterization, and structural effects on gene delivery. J Control Release 126: 166-174, 2008.
64. Lin C, Zhong Z, Lok MC, Jiang X, Hennink WE, Feijen J, and Engbersen JF. Novel bioreducible poly(amido amine)s for highly efficient gene delivery. Bioconjug Chem 18: 138-145, 2007.
65. Maier K, Martin I, and Wagner E. Sequence defined disulfide-linked shuttle for strongly enhanced intracellular protein delivery. Mol Pharm 9: 3560-3568, 2012.
66. Maier K and Wagner E. Acid-labile traceless click linker for protein transduction. J Am Chem Soc 134: 10169-10173, 2012.
67. Matsumoto S, Christie RJ, Nishiyama N, Miyata K, Ishii A, Oba M, Koyama H, Yamasaki Y, and Kataoka K. Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery. Biomacromolecules 10: 119-127, 2009.
68. McKenzie DL, Kwok KY, and Rice KG. A potent new class of reductively activated peptide gene delivery agents. J Biol Chem 275: 9970-9977, 2000.
69. Mercer J, Schelhaas M, and Helenius A. Virus entry by endocytosis. Annu Rev Biochem 79: 803-833, 2010.
70. Meyer M, Dohmen C, Philipp A, Kiener D, Maiwald G, Scheu C, Ogris M, and Wagner E. Synthesis and biological evaluation of a bioresponsive and endosomolytic siRNA-polymer conjugate. Mol Pharm 6: 752-762, 2009.
71. Meyer M, Philipp A, Oskuee R, Schmidt C, and Wagner E. Breathing life into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery. J Am Chem Soc 130: 3272-3273, 2008.
72. Meyer M and Wagner E. pH-responsive shielding of nonviral gene vectors. Expert Opin Drug Deliv 3: 563-571, 2006.
73. Midoux P and Monsigny M. Efficient gene transfer by histidylated polylysine/pDNA complexes. Bioconjug Chem 10: 406-411, 1999.
74. Moghimi SM, Symonds P, Murray JC, Hunter AC, Debska G, and Szewczyk A. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/ therapy. Mol Ther 11: 990-995, 2005.
75. Mok H, Lee SH, Park JW, and Park TG. Multimeric small interfering ribonucleic acid for highly efficient sequencespecific gene silencing. Nat Mater 9: 272-278, 2010.
76. Nie Y, GüntherM, Gu Z, andWagner E. Pyridylhydrazonebased PEGylation for pH-reversible lipopolyplex shielding. Biomaterials 32: 858-869, 2011.
77. Noiva R. Protein disulfide isomerase: the multifunctional redox chaperone of the endoplasmic reticulum. Semin Cell Dev Biol 10: 481-493, 1999.
78. Oh KJ, Senzel L, Collier RJ, and Finkelstein A. Translocation of the catalytic domain of diphtheria toxin across planar phospholipid bilayers by its own T domain. Proc Natl Acad Sci USA 96: 8467-8470, 1999.
79. Pack DW, Hoffman AS, Pun S, and Stayton PS. Design and development of polymers for gene delivery. Nat Rev Drug Discov 4: 581-593, 2005.
80. Parmar RG, Busuek M, Walsh ES, Leander KR, Howell BJ, Sepp-Lorenzino L, Kemp E, Crocker LS, Leone A, Kochansky CJ, Carr BA, Garbaccio RM, Colletti SL, and Wang W. Endosomolytic bioreducible Poly(amido amine disulfide) polymer conjugates for the in vivo systemic delivery of siRNA therapeutics. Bioconjug Chem 24: 640-647, 2013.
81. Pichon C, Roufai MB, Monsigny M, and Midoux P. Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides. Nucleic Acids Res 28: 504-512, 2000.
82. Ping Y, Hu Q, Tang G, and Li J. FGFR-targeted gene delivery mediated by supramolecular assembly between beta-cyclodextrin-crosslinked PEI and redox-sensitive PEG. Biomaterials 34: 6482-6494, 2013.
83. Pirazzini M, Bordin F, Rossetto O, Shone CC, Binz T, and Montecucco C. The thioredoxin reductase-thioredoxin system is involved in the entry of tetanus and botulinum neurotoxins in the cytosol of nerve terminals. FEBS Lett 587: 150-155, 2013.
84. Plank C, Mechtler K, Szoka FC, Jr., and Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther 7: 1437-1446, 1996.
85. Prochiantz A. Messenger proteins: homeoproteins, TAT and others. Curr Opin Cell Biol 12: 400-406, 2000.
86. Ratts R, Zeng H, Berg EA, Blue C, McComb ME, Costello CE, vanderSpek JC, and Murphy JR. The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex. J Cell Biol 160: 1139-1150, 2003.
87. Read ML, Bremner KH, Oupický D, Green NK, Searle PF, and Seymour LW. Vectors based on reducible polycations facilitate intracellular release of nucleic acids. J Gene Med 5: 232-245, 2003.
88. Read ML, Singh S, Ahmed Z, Stevenson M, Briggs SS, Oupicky D, Barrett LB, Spice R, Kendall M, Berry M, Preece JA, Logan A, and Seymour LW. A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res 33: e86, 2005.
89. Russ V, Elfberg H, Thoma C, Kloeckner J, Ogris M, and Wagner E. Novel degradable oligoethylenimine acrylate ester-based pseudodendrimers for in vitro and in vivo gene transfer. Gene Ther 15: 18-29, 2008.
90. Saito G, Amidon GL, and Lee KD. Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential. Gene Ther 10: 72-83, 2003.
91. Saito G, Swanson JA, and Lee KD. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Deliv Rev 55: 199-215, 2003.
92. Salcher EE, Kos P, Frohlich T, Badgujar N, Scheible M, and Wagner E. Sequence-defined four-arm oligo(ethanamino)amides for pDNA and siRNA delivery: Impact of building blocks on efficacy. J Control Release 164: 380-386, 2012.
93. Sawant R and Torchilin V. Intracellular transduction using cell-penetrating peptides. Mol Biosyst 6: 628-640, 2010.
94. Schafer FQ and Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30: 1191-1212, 2001.
95. Schaffer DV, Fidelman NA, Dan N, and Lauffenburger DA. Vector unpacking as a potential barrier for receptormediated polyplex gene delivery. Biotechnol Bioeng 67: 598-606, 2000.
96. Schaffert D, Badgujar N, and Wagner E. Novel Fmocpolyamino acids for solid-phase synthesis of defined polyamidoamines. Org Lett 13: 1586-1589, 2011.
97. Schaffert D, Troiber C, Salcher EE, Frohlich T, Martin I, Badgujar N, Dohmen C, Edinger D, Klager R, Maiwald G, Farkasova K, Seeber S, Jahn-Hofmann K, Hadwiger P, and Wagner E. Solid-phase synthesis of sequence-defined T-, i-, and U-shape polymers for pDNA and siRNA delivery. Angew Chem Int Ed Engl 50: 8986-8989, 2011.
98. Schaffert D, Troiber C, and Wagner E. New sequencedefined polyaminoamides with tailored endosomolytic properties for plasmid DNA delivery. Bioconjug Chem 23: 1157-1165, 2012.
99. Schelhaas M, Malmstrom J, Pelkmans L, Haugstetter J, Ellgaard L, Grunewald K, and Helenius A. Simian Virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell 131: 516-529, 2007.
100. Schlossbauer A, Dohmen C, Schaffert D, Wagner E, and Bein T. pH-responsive release of acetal-linked melittin from SBA-15 mesoporous silica. Angew Chem Int Ed Engl 50: 6828-6830, 2011.
101. Schnell R, Borchmann P, Staak JO, Schindler J, Ghetie V, Vitetta ES, and Engert A. Clinical evaluation of ricin Achain immunotoxins in patients with Hodgkin's lymphoma. Ann Oncol 14: 729-736, 2003.
102. Scholz C and Wagner E. Therapeutic plasmid DNA versus siRNA delivery: Common and different tasks for synthetic carriers. J Control Release 161: 554-565, 2012.
103. Schwarze SR, Ho A, Vocero-Akbani A, and Dowdy SF. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285: 1569-1572, 1999.
104. Son S, Namgung R, Kim J, Singha K, and Kim WJ. Bioreducible polymers for gene silencing and delivery. Acc Chem Res 45: 1100-1112, 2012.
105. Sonawane ND, Szoka FC, Jr., and Verkman AS. Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes. J Biol Chem 278: 44826-44831, 2003.
106. Stolnik S and Shakesheff K. Formulations for delivery of therapeutic proteins. Biotechnol Lett 31: 1-11, 2009.
107. Sun H, Guo B, Cheng R, Meng F, Liu H, and Zhong Z. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials 30: 6358-6366, 2009.
108. Tanna AP, Budenz DL, Bandi J, Feuer WJ, Feldman RM, Herndon LW, Rhee DJ, Whiteside-de Vos J, Huang J, and Anderson DR. Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma. Ophthalmology 119: 468-473, 2012.
109. Thomas M, Ge Q, Lu JJ, Chen J, and Klibanov AM. Cross-linked small polyethylenimines: while still nontoxic, deliver DNA efficiently to mammalian cells in vitro and in vivo. Pharm Res 22: 373-380, 2005.
110. Thorpe PE, Wallace PM, Knowles PP, Relf MG, Brown AN, Watson GJ, Knyba RE, Wawrzynczak EJ, and Blakey DC. New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. Cancer Res 47: 5924-5931, 1987.
111. Troiber C, Kasper JC, Milani S, Scheible M, Martin I, Schaubhut F, Kuchler S, Radler J, Simmel FC, Friess W, and Wagner E. Comparison of four different particle sizing methods for siRNA polyplex characterization. Eur J Pharm Biopharm 84: 255-264, 2012.
112. Tsai B, Rodighiero C, Lencer WI, and Rapoport TA. Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin. Cell 104: 937-948, 2001.
113. Tuschl T. RNA interference and small interfering RNAs. Chembiochem 2: 239-245, 2001.
114. Vincenzi B, Zoccoli A, Pantano F, Venditti O, and Galluzzo S. CETUXIMAB: From Bench to Bedside. Curr Cancer Drug Targets 10: 80-95, 2010.
115. von Harpe A, Petersen H, Li Y, and Kissel T. Characterization of commercially available and synthesized polyethylenimines for gene delivery. J Control Release 69: 309-322, 2000.
116. Wagner E. Programmed drug delivery: nanosystems for tumor targeting. Expert Opin Biol Ther 7: 587-593, 2007.
117. Wagner E. Polymers for siRNA Delivery: Inspired by Viruses to be Targeted, Dynamic, and Precise. Acc Chem Res 45: 1005-1013, 2012.
118. Wagner E. Biomaterials in RNAi therapeutics: quo vadis? Biomater Sci 1: 804-809, 2013.
119. Wagner E and Kloeckner J. Gene delivery using polymer therapeutics. Adv Polym Sci 192: 135-173, 2006.
120. Walczak CP, Bernardi KM, and Tsai B. Endoplasmic reticulum-dependent redox reactions control endoplasmic reticulum-associated degradation and pathogen entry. Antioxid Redox Signal 16: 809-818, 2012.
121. Walker GF, Fella C, Pelisek J, Fahrmeir J, Boeckle S, Ogris M, and Wagner E. Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. Mol Ther 11: 418-425, 2005.
122. Wang X-L, Xu R, and Lu Z-R. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery. J Control Release 134: 207-213, 2009.
123. Wernick NL, Chinnapen DJ, Cho JA, and Lencer WI. Cholera toxin: an intracellular journey into the cytosol by way of the endoplasmic reticulum. Toxins (Basel) 2: 310-325, 2010.
124. Wolfert MA and Seymour LW. Atomic force microscopic analysis of the influence of the molecular weight of poly(L)lysine on the size of polyelectrolyte complexes formed with DNA 723. Gene Ther 3: 269-273, 1996.
125. Wu C, Belenda C, Leroux JC, and Gauthier MA. Interplay of chemical microenvironment and redox environment on thiol-disulfide exchange kinetics. Chemistry 17: 10064-10070, 2011.
126. Wu C, Leroux JC, and Gauthier MA. Twin disulfides for orthogonal disulfide pairing and the directed folding of multicyclic peptides. Nat Chem 4: 1044-1049, 2012.
127. Xia CQ, Wang J, and Shen WC. Hypoglycemic effect of insulin-transferrin conjugate in streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 295: 594-600, 2000.
128. Zhang G, Liu J, Yang Q, Zhuo R, and Jiang X. Disulfidecontaining brushed polyethylenimine derivative synthesized by click chemistry for nonviral gene delivery. Bioconjug Chem, 23: 1290-1299, 2012.
129. Ziady AG, Ferkol T, Dawson DV, Perlmutter DH, and Davis PB. Chain length of the polylysine in receptortargeted gene transfer complexes affects duration of reporter gene expression both in vitro and in vivo. J Biol Chem 274: 4908-4916, 1999.
130. Zinselmeyer BH, Mackay SP, Schatzlein AG, and Uchegbu IF. The lower-generation polypropylenimine dendrimers are effective gene-transfer agents. Pharm Res 19: 960-967, 2002.
131. Zou SM, Erbacher P, Remy JS, and Behr JP. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J Gene Med 2: 128-134, 2000.